Koyfin Home > Directory > Health Care > Aclaris Therapts > EBITDA

Aclaris Therapts EBITDA Chart (ACRS)

Aclaris Therapts annual/quarterly EBITDA from 2014 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Aclaris Therapts EBITDA for the quarter ending June 06, 2020 was $-11m a -96.45% increase of 11m year over year
  • Aclaris Therapts EBITDA for the last 12 months ending June 06, 2020 was $-67m a -43.61% increase of 29m year over year
  • Aclaris Therapts Annual EBITDA for 2019 was $-89m a 8.00% decrease of -7m from 2018
  • Aclaris Therapts Annual EBITDA for 2018 was $-82m a 34.96% decrease of -29m from 2017
  • Aclaris Therapts Annual EBITDA for 2017 was $-53m a 9.77% decrease of -5m from 2016
Other Income Statement Metrics:
  • Aclaris Therapts Net Income for the quarter ending September 09, 2018 was $-33m a 29.95% decrease of -10m year over year
  • Aclaris Therapts Total Revenue for the quarter ending September 09, 2018 was $2m a 38.64% increase of 1m year over year
View Chart On Koyfin

Quarterly ACRS EBITDA Data

06/2020$-11m
03/2020$-13m
12/2019$-17m
09/2019$-22m
06/2019$-22m
03/2019$-25m
12/2018$-23m
09/2018$-21m
03/2018$-30m
12/2017$-25m

Annual ACRS EBITDA Data

2019$-89m
2018$-82m
2017$-53m
2016$-48m
2015$-20m
2014$-9m
2013$-5m